Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized double-blind study of weekly etanercept 100 mg vs 50 mg in ankylosing spondylitis
2006-002349-35Phase 4Completed
- Sponsor
- Wyeth Farma
- Start
- Aug 2006
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of etanercept in ankylosing spondylitis (AS) (2 arms), sponsored by Wyeth Farma. Started Aug 2006; status: completed.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on 2006-002349-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002349-35.